2018
Association of Bariatric Surgery and National Medication Use
Morton JM, Ponce J, Malangone-Monaco E, Nguyen N. Association of Bariatric Surgery and National Medication Use. Journal Of The American College Of Surgeons 2018, 228: 171-179. PMID: 30453056, DOI: 10.1016/j.jamcollsurg.2018.10.021.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBariatric SurgeryCardiovascular AgentsDrug UtilizationFemaleHealth Care CostsHumansHypoglycemic AgentsLongitudinal StudiesMaleMatched-Pair AnalysisMiddle AgedObesity, MorbidPostoperative PeriodPropensity ScoreRetrospective StudiesUnited StatesYoung AdultConceptsNonsurgical control patientsBariatric surgical patientsControl patientsSurgical patientsMedication useControl groupSurgical groupPharmacy costsPropensity-matched control groupTruven Health Analytics MarketScan Commercial ClaimsBariatric surgical proceduresMarketScan Commercial ClaimsTotal pharmacy costsLower pharmacy costsNonsurgical control groupEnduring treatmentGastric bypassIndex dateBariatric surgeryObese patientsPostoperative periodSevere obesitySurgical cohortBariatric operationsEncounters Database
2012
The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity
Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, Reeds DN, Eagon JC, Wolfe BM, O’Rourke R, Fujioka K, Takata M, Swain JM, Morton JM, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R, The EMPOWER Study Group. The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity. Obesity Surgery 2012, 22: 1771-1782. PMID: 22956251, DOI: 10.1007/s11695-012-0751-8.Peer-Reviewed Original ResearchConceptsImportant weight lossControl groupWeight lossMorbid obesityVagal blockadePercent excess weight lossSubdiaphragmatic vagal nerveExcess weight lossSerious adverse eventsDuration of therapyDevice-related complicationsBody mass indexMain outcome measuresDevice useResultsStudy subjectsVagal transmissionAdverse eventsVagal nerveMulticenter trialMass indexFeasibility trialEMPOWER studyOutcome measuresInformed consentTherapy
2009
Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or Without Neuroglycopenia
Kim SH, Liu TC, Abbasi F, Lamendola C, Morton JM, Reaven GM, McLaughlin TL. Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or Without Neuroglycopenia. Obesity Surgery 2009, 19: 1550. PMID: 19557485, DOI: 10.1007/s11695-009-9893-8.Peer-Reviewed Original ResearchConceptsGastric bypass surgeryInsulin sensitivityOral glucoseInsulin concentrationsPost-RYGBBypass surgeryPlasma glucoseInsulin responseControl groupOverweight/obese controlsInsulin suppression testOral glucose challengePeak insulin concentrationsNon-surgical controlsNadir glucose concentrationsAsymptomatic patientsSymptomatic hypoglycemiaObese controlsRYGB groupGlucose challengeSuppression testPeak glucosePatientsRYGBGlucose concentrationProbiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial
Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, Morton JM. Probiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial. Journal Of Gastrointestinal Surgery 2009, 13: 1198-1204. PMID: 19381735, DOI: 10.1007/s11605-009-0891-x.Peer-Reviewed Original ResearchMeSH KeywordsAdultBody Mass IndexConfidence IntervalsDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesGastric BypassHumansMaleMiddle AgedObesity, MorbidPatient SatisfactionPostoperative CarePostoperative ComplicationsProbabilityProbioticsProspective StudiesReference ValuesRisk AssessmentTreatment OutcomeWeight LossConceptsGastric bypass surgeryBacterial overgrowthProbiotic groupControl groupWeight lossBypass surgeryGreater percent excess weight lossPercent excess weight lossY Gastric Bypass SurgeryExcess weight lossProspective randomized trialsVitamin B12 levelsMethodsForty-four patientsQuality of lifeEnduring treatmentGastric bypassMorbid obesityB12 levelsPostoperative changesResultsAt 6Randomized trialsVitamin B12 availabilityProbiotic administrationGastrointestinal floraGI microbiota
2007
Does gastric bypass alter alcohol metabolism?
Hagedorn JC, Encarnacion B, Brat GA, Morton JM. Does gastric bypass alter alcohol metabolism? Surgery For Obesity And Related Diseases 2007, 3: 543-548. PMID: 17903777, DOI: 10.1016/j.soard.2007.07.003.Peer-Reviewed Original ResearchConceptsGastric bypass patientsGastric bypass groupBypass patientsBypass groupAlcohol metabolismBreath levelsControl groupBody mass index lossPostoperative gastric bypass patientsAlcohol levelsBody mass indexGastric bypassMorbid obesityBariatric surgeryPublic health crisisMass indexControl subjectsMore symptomsPatientsSymptom profilesIndex lossAlcohol useAverage timeBypassSymptoms
2004
Bovine pericardium buttress limits recanalization of the uncut roux-en-Y in a porcine model
Morton J, Lucktong T, Trasti S, Farrell T. Bovine pericardium buttress limits recanalization of the uncut roux-en-Y in a porcine model. Journal Of Gastrointestinal Surgery 2004, 8: 127-131. PMID: 14746845, DOI: 10.1016/j.gassur.2003.09.024.Peer-Reviewed Original Research